U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07791758) titled 'A Phase Ib/II Clinical Study of LBL-024 Combination Therapy in Patients With Metastatic Colorectal Carcinoma' on Aug. 25.
Brief Summary: This study is an open-label, multi-center Phase Ib/II clinical trial evaluating the safety and efficacy of LBL-024 in combination with other drugs for the treatment of metastatic colorectal carcinoma (mCRC), aiming to evaluate the safety and efficacy of LBL-024 in combination with other drugs in the treatment of mCRC patients.
Study Start Date: Sept. 04
Study Type: INTERVENTIONAL
Condition:
Metastatic Colorectal Carcinoma
Intervention:
DRUG: LBL-024 for Injection
intravenous infusion.
DRUG:...